Literature DB >> 12069810

Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols.

Daniela Corda1, Cristiano Iurisci, Christopher P Berrie.   

Abstract

The lysophospholipids are integral components of the plasma membrane that have often been considered as side products of the phospholipase A2 (PLA2)-dependent production of arachidonic acid and the deacylation/reacylation processes involved in phospholipid homeostasis. Data indicating roles of these lipid derivatives in hormone responses and cell transformation have now led to a different view, and the understanding of their involvement in the modulation of cell function is building up. Here, we will summarise the current knowledge concerning the biological roles of the lysophosphoinositides and the glycerophosphoinositols (their fully deacylated counterparts) in the framework of their known effects, and those of the other lysophospholipids and glycerophospholipids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069810     DOI: 10.1016/s1388-1981(02)00137-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

Review 1.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

2.  Robust utilization of phospholipase-generated metabolites, glycerophosphodiesters, by Candida albicans: role of the CaGit1 permease.

Authors:  Andrew C Bishop; Tao Sun; Mitchell E Johnson; Vincent M Bruno; Jana Patton-Vogt
Journal:  Eukaryot Cell       Date:  2011-10-07

3.  A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanism.

Authors:  Yuri Okazaki; Noriyasu Ohshima; Ikumi Yoshizawa; Yasutomi Kamei; Stefania Mariggiò; Keiko Okamoto; Masahiro Maeda; Yoshihito Nogusa; Yuichiro Fujioka; Takashi Izumi; Yoshihiro Ogawa; Yoshitsugu Shiro; Masanobu Wada; Norihisa Kato; Daniela Corda; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

4.  GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.

Authors:  Nariman A B Balenga; Elma Aflaki; Julia Kargl; Wolfgang Platzer; Ralf Schröder; Stefanie Blättermann; Evi Kostenis; Andrew J Brown; Akos Heinemann; Maria Waldhoer
Journal:  Cell Res       Date:  2011-04-05       Impact factor: 25.617

5.  The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses.

Authors:  Mariangela Vessichelli; Stefania Mariggiò; Alessia Varone; Pasquale Zizza; Angelomaria Di Santo; Concetta Amore; Giuseppe Dell'Elba; Adele Cutignano; Angelo Fontana; Carmela Cacciapuoti; Gaetano Di Costanzo; Mariastella Zannini; Tiziana de Cristofaro; Virgilio Evangelista; Daniela Corda
Journal:  J Biol Chem       Date:  2017-06-09       Impact factor: 5.157

6.  Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.

Authors:  Gracious R Ross; Aron Lichtman; William L Dewey; Hamid I Akbarali
Journal:  Pharmacology       Date:  2012-06-28       Impact factor: 2.547

7.  The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth.

Authors:  Daniela Corda; Takahiro Kudo; Pasquale Zizza; Cristiano Iurisci; Eri Kawai; Norihisa Kato; Noriyuki Yanaka; Stefania Mariggiò
Journal:  J Biol Chem       Date:  2009-07-13       Impact factor: 5.157

8.  GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.

Authors:  Alexander Bondarenko; Markus Waldeck-Weiermair; Shamim Naghdi; Michael Poteser; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 9.  Receptors for acylethanolamides-GPR55 and GPR119.

Authors:  Grzegorz Godlewski; László Offertáler; Jens A Wagner; George Kunos
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-07-15       Impact factor: 3.072

10.  Salicylate enables cochlear arachidonic-acid-sensitive NMDA receptor responses.

Authors:  Jérôme Ruel; Christian Chabbert; Régis Nouvian; Rim Bendris; Michel Eybalin; Claude Louis Leger; Jérôme Bourien; Marcel Mersel; Jean-Luc Puel
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.